Form SC 13G - Statement of Beneficial Ownership by Certain Investors:
SEC Accession No. 0001193125-19-042232
Filing Date
2019-02-15
Accepted
2019-02-15 14:42:32
Documents
1

Document Format Files

Seq Description Document Type Size
1 SC 13G d691304dsc13g.htm SC 13G 41553
  Complete submission text file 0001193125-19-042232.txt   43238
Mailing Address 100 CAMPUS DRIVE FLORHAM PARK NJ 07932
Business Address 100 CAMPUS DRIVE FLORHAM PARK NJ 07932 (608) 441-8120
Cellectar Biosciences, Inc. (Subject) CIK: 0001279704 (see all company filings)

IRS No.: 043321804 | State of Incorp.: DE | Fiscal Year End: 1231
Type: SC 13G | Act: 34 | File No.: 005-85798 | Film No.: 19611047
SIC: 2834 Pharmaceutical Preparations

Mailing Address BAHNHOFSTRASSE 45 ZURICH V8 CH-8001
Business Address BAHNHOFSTRASSE 45 ZURICH V8 CH-8001 41-44-234-1111
UBS Group AG (Filed by) CIK: 0001610520 (see all company filings)

IRS No.: 000000000 | State of Incorp.: V8 | Fiscal Year End: 1231
Type: SC 13G
SIC: 6021 National Commercial Banks